Fed. Circ. Reverses Rejection Of Psoriasis Drug Patent

Law360, Los Angeles (November 22, 2013, 4:17 PM EST) -- The Federal Circuit on Friday overturned the U.S. Patent and Trademark Office's rejection of claims in an inventor's patent application for a psoriasis treatment, finding the office failed to support its findings that the claims were invalid as anticipated and obvious. 

A three-judge panel reversed the Patent Trial and Appeal Board's decision affirming a patent examiner's rejection of claims in Kevin P. Eaton's U.S. Patent Application 11,145,716, and remanded for further proceedings. In reversing the ruling, the Federal Circuit panel said the appeal board misconstrued a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In re: Eaton


Case Number

13-1104

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

December 5, 2012

Law Firms

Government Agencies

Patents

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.